Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fabian

Showing results (261-270 of 276) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulatorCarol J Fabian, Bruce F Kimler, Julie Anderson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 22, 2020
Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast CancerCarol J Fabian, Seema A Khan, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARFGregory R Bean, Andrew D Bryson, Patrick G Pilie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent developmentJoyce A O'Shaughnessy, Gary J Kelloff, Gary B Gordon, et al.
The New England Journal of Medicine|March 5, 2015
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyHalle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.
Science Advances|October 30, 2024
Metropolitan-scale heralded entanglement of solid-state qubitsArian J Stolk, Kian L van der Enden, Marie-Christine Slater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Journal of the National Cancer Institute|October 30, 2018
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230Halle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.
Gene Therapy|November 30, 2022
In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse modelYi A Chen, Mark W Kankel, Sam Hana, et al.
Nature|February 11, 2011
Telomere dysfunction induces metabolic and mitochondrial compromiseErgün Sahin, Simona Colla, Marc Liesa, et al.
Pageof 28

Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulatorCarol J Fabian, Bruce F Kimler, Julie Anderson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 22, 2020
Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast CancerCarol J Fabian, Seema A Khan, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARFGregory R Bean, Andrew D Bryson, Patrick G Pilie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent developmentJoyce A O'Shaughnessy, Gary J Kelloff, Gary B Gordon, et al.
The New England Journal of Medicine|March 5, 2015
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyHalle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.
Science Advances|October 30, 2024
Metropolitan-scale heralded entanglement of solid-state qubitsArian J Stolk, Kian L van der Enden, Marie-Christine Slater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Journal of the National Cancer Institute|October 30, 2018
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230Halle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.
Gene Therapy|November 30, 2022
In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse modelYi A Chen, Mark W Kankel, Sam Hana, et al.
Nature|February 11, 2011
Telomere dysfunction induces metabolic and mitochondrial compromiseErgün Sahin, Simona Colla, Marc Liesa, et al.
Pageof 28